Pacific Biosciences of California Inc
PACB
Get informed when a big investor buys or sells
+ FollowMarket Cap$434.84M
Close$
$5.61
315.3% upside
Current Fair Value
315.3% upsideUndervalued by 315.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $434.84 Million |
|---|---|
| Enterprise Value | $1.10 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.82 |
| Beta | 2.32 |
| Outstanding Shares | 310,655,000 |
Return
| Return on Equity | 395.59% |
|---|---|
| Return on Assets | -17.48% |
| Return on Invested Capital | -23.39% |
Valuation & Multiples
| P/E Ratio | -3.26 |
|---|---|
| PEG | -48.57 |
| Price to Sales | - |
| Price to Book Ratio | -1.35 |
| Enterprise Value to Revenue | 6.88 |
| Enterprise Value to EBIT | -6.86 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.66 |
| Debt to Equity | -21.75 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 3, 2026
EPS Estimate
$-0.13
Average shareholder expectationRevenue Estimate
$42.90 M
Average shareholder expectationNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
$-0.13
Average shareholder expectationRevenue Estimate
$43.82 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.1227▲ 76.68% |
|---|---|
| Total Calls | 574,800▼ 76.83% |
| Total Puts | 645,300▼ 26.89% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 61.54%▼ 5.39% |
|---|---|
| Total Invested | $248.55M▼ 33.46% |
| Investors Holding | 237▲ 12.00% |
ESG Score
No data